Research generating evidence to optimise pneumococcal disease prevention
- Funded by National Health and Medical Research Council (NHMRC)
- Total publications:3 publications
Grant number: 2010091
Grant search
Key facts
Disease
COVID-19Known Financial Commitments (USD)
$329,670.84Funder
National Health and Medical Research Council (NHMRC)Principal Investigator
Dr. Sanjay Jayasinghe Wadanambi ArachchigeResearch Location
AustraliaLead Research Institution
University of SydneyResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Disease pathogenesis
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
This research program aims to develop an in-depth understanding of various streptococcus pneumoniae (SP) infections that could be serious and even life threatening. Antibiotic resistance and how COVID-19 and influenza could make people vulnerable to SP infections will be two key areas explored. This research is expected to feed directly in to practice and policy relating to pneumococcal disease surveillance and optimizing prevention using vaccinations during COVID-19 pandemic and beyond.
Publicationslinked via Europe PMC
Last Updated:an hour ago
View all publications at Europe PMC